These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


433 related items for PubMed ID: 2292234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clozapine: a clinical review of adverse effects and management.
    Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM.
    Ann Clin Psychiatry; 2003 Mar; 15(1):33-48. PubMed ID: 12839431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Leponex, 10 years after -- a clinical review].
    Llorca PM, Pere JJ.
    Encephale; 2004 Mar; 30(5):474-91. PubMed ID: 15627052
    [Abstract] [Full Text] [Related]

  • 7. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
    Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM.
    Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
    [Abstract] [Full Text] [Related]

  • 8. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
    Mattes JA.
    J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
    [Abstract] [Full Text] [Related]

  • 9. Clozapine: an atypical antipsychotic agent.
    Ereshefsky L, Watanabe MD, Tran-Johnson TK.
    Clin Pharm; 1989 Oct; 8(10):691-709. PubMed ID: 2572373
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.
    Kane JM.
    Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888
    [Abstract] [Full Text] [Related]

  • 16. Clozapine: current status and role in the pharmacotherapy of schizophrenia.
    Remington GJ, Addington D, Collins EJ, Jones BD, Lalonde P, MacCrimmon DJ, MacEwan GW.
    Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645
    [Abstract] [Full Text] [Related]

  • 17. Management of schizophrenia in children and adolescents. The role of clozapine.
    Remschmidt H, Fleischhaker C, Hennighausen K, Schulz E.
    Paediatr Drugs; 2000 Apr; 2(4):253-62. PubMed ID: 10946414
    [Abstract] [Full Text] [Related]

  • 18. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K.
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [Abstract] [Full Text] [Related]

  • 19. Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.
    Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M.
    Pharmacol Ther; 2018 Dec; 192():20-41. PubMed ID: 29953902
    [Abstract] [Full Text] [Related]

  • 20. Treatment of the neuroleptic-nonresponsive schizophrenic patient.
    Meltzer HY.
    Schizophr Bull; 1992 Dec; 18(3):515-42. PubMed ID: 1357741
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.